Search Results
Results found for "Glaxo Inc"
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
natural environment or post-translational modifications observed in humans, potentially leading to inconsistencies Moreover, DMS requires considerable resources, including time, financial investment, and specialised Another promising development is the application of DMS to a wider array of biological systems, including
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
possibility of dimerization in class A and class B GPCRs, however, has been more controversial, despite increasing Class B1 GPCRs are an important subclass of GPCRs that include 15 receptors involved in regulating body Examples of class B1 GPCRs forming homodimers include the secretin receptor (SecR)[6] and GLP-1R [7], SecR dimerization enhances the receptor’s signaling efficiency by increasing its dynamics in a G protein-dependent
- Profiling Immune Cell and Platelet Transcriptomes
Additionally, the study identified unique expression patterns of GPCRs in different immune cell types, including manner also opens doors for exploring the roles of these receptors in various pathological states, including
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Allow registrants to appreciate the incredible versatility of GPCRs and how small molecules can affect
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
This Week’s Highlights: Congrats to: Our contributor, Cam Sinh Lu ,  who has just released an incredible
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
inhibit receptor activity without directly competing with ligands, potentially reducing side effects and increasing GPCRs, including β2AR, play key roles in various conditions, such as asthma, cardiovascular diseases,
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
AlphaFold3, the latest version, has improved on this by modeling interactions with various compounds, including
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
our understanding of the molecular basis of biased agonism continues to grow, it is likely to play an increasingly Indeed, incretin-based drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound are advancing diabetes Anson, M., et al., Incidence of new onset type 2 diabetes in adults living with obesity treated with
- Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024
, MA đź“… October 2 -3, 2024 Join top researchers to explore the latest in GPCR-targeted drug design, including
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Hello GPCR Community, Stay up-to-date with the latest GPCR research, including breakthrough studies, This week's highlights include congrats to: Bruce Allen , Terence Hébert , et al. for their work on Understanding online) gathers top researchers to explore the latest advances in designing precise GPCR-targeted drugs, including Small-Molecule Antagonists Targeting the Growth Hormone Releasing Hormone Receptor (GHRHR) Delivery of US28 by incoming
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
This technique has uncovered fundamental aspects of the G protein-coupled receptor (GPCR) function, including To overcome these challenges, future directions include developing high-throughput techniques, better Future advancements, including high-throughput techniques and bioinformatics integration, will further
- 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!
October 31, November 7, 14, 21, December 5 (five sessions) Courses Highlights Act Fast: Don’t miss this incredible Topics include pharmacologic activity measurement, mechanisms of action, and GPCR discovery strategies
- đź“° GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
Dear GPCR Community, Before diving into this week's news, prepare for an incredible learning journey! This week's highlight includes congrats to: Madison Walker , Benjamin Myers , et al., for their research
- đź“° GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
Perks Include: In-depth Reading Materials Access to a Private Community Certificate of Participation This week's highlight includes congrats to: Miles Thompson , Â Alexander Hauser , Â Caroline Gorvin ,
- Dr. GPCR University registration is now open! Secure your spot now!
This week's highlight includes congrats to: Clementine E Philibert and Mikel Garcia-Marcos for their
- Unlocking the Future of Medicine: Advancements in GPCR Research
This week's highlight includes congrats to Omolade Otun, Chris de Graaf, Cherine Bechara, et al. for
- Exploring the Breakthroughs in GPCR Research
This week's highlight includes congrats to: Remi Janicot, and Dr. Topics include the complex pleiotropic behaviors of GPCRs and how these can be harnessed for innovative
- đź“° GPCR Weekly News, July 1 to 7, 2024
This week's highlight includes congrats to Edda Matthees, Drs.Â
- đź“° GPCR Weekly News, June 24 to 30, 2024
This week's highlight includes congrats to: Drs.
- đź“° GPCR Weekly News, June 17 to 23, 2024
This Thursday, explore the latest content on GPCRs, which includes 29 informative research papers and This week's highlight includes congrats to: Ya-Tzu Li for her contributor article titled Do You Believe
- đź“° GPCR Weekly News, June 10 to 16, 2024
Hi everyone, Take a moment to explore our latest coverage of GPCRs this week, which includes 7 insightful This week's highlight includes congrats to: Dr.
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
Instead, G12 overexpression inhibited V2R downstream signalling, including β-arrestin recruitment and Overall, the increased calcium signalling was attributed to the release of ATP via β2AR-Gs mediated activation However, IP1 signalling through the non-cognate Gq was not important for the increased β2AR-Gs-mediated Stallaert, W., et al., Purinergic Receptor Transactivation by the β(2)-Adrenergic Receptor Increases
- đź“° GPCR Weekly News, June 3 to June 9, 2024
Hi everyone, Please take a moment to explore our most recent coverage of GPCRs this week, which includes This week's highlight includes congrats to: Dr. rhodopsin triggers distinct endocytic trafficking and recycling in vivo via differential phosphorylation Increased Therapeutics Strengthens Its Intellectual Property for Its Series of Treg Depleting anti-CCR8 Antibodies, Including
- Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered
Key findings include: Phosphorylation Hotspots: P Loop (Ser44, Ser47, Thr48): Impairs ligand-stimulated
- đź“° GPCR Weekly News, May 27 to June 2, 2024
This week's highlight includes congrats to: InĂŞs Pinheiro, for her Dr.
- Canonical chemokine receptors as scavenging “decoys”
mimicking inflammation, CCR1, CCR2, and CCR5 switch purely to scavenging (D'Amico G. et al. 2000), becoming incapable
- đź“° GPCR Weekly News, May 20 to 26, 2024
This week's highlight includes congrats to: Cam Sinh Lu, for his first Dr.
- Adhesion GPCR Consortium Newsletter - May 2024
deal for many, but in this new era of making sure that historically excluded demographics are finally included
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
Once activated, ERKs translocate to the nucleus, phosphorylating various transcription factors, including In various pathological conditions, including cancer, aberrant ERK activity can lead to uncontrolled These include infrared fluorescence, electrochemiluminescence, fluorescence emission, immunofluorescence
- đź“° GPCR Weekly News, May 13 to 19, 2024
This week's highlight includes congrats to: John Teye Azietaku for his first contributor article on Illuminating Access recorded material from previous events, including the Dr. GPCR Summit editions.

















